Saving Lives Through Innovative Antimicrobial Solutions
Antibiotic overprescription has led to a rise in antimicrobial resistance, posing a clear and present danger to modern medicine and worldwide health. Arkstone empowers the healthcare community with tools to make informed medical decisions and reduce that threat.
Impact
Our Commitment to Combatting Antimicrobial Resistance and Saving Lives
To save as many lives as possible by reducing the global spread of antimicrobial-resistant bacteria and the misuse of antibiotics through continued education, advanced technology, and guidance to the medical community.
700K
Worldwide annual deaths due to Antimicrobial Resistance
50%
Of outpatient antibiotic prescriptions are unnecessary or inappropriate
$20B
Estimated additional cost to U.S. Healthcare System each year
10M
By 2050, drug-resistant infections could cause 10 million deaths annually if not controlled (WHO, 2024).
Innovative
Leading the Future of Antimicrobial Stewardship
At Arkstone, we are proud to support over 150 laboratories worldwide in their antimicrobial stewardship efforts. Our AI-powered solutions enhance clinical decision-making, ensuring better patient outcomes and optimized resource use. With a commitment to innovation and excellence, we are transforming the landscape of infectious disease management.
10M
By 2050, drug-resistant infections could cause 10 million deaths annually if not controlled (WHO, 2024).
50%
Up to 50% of antibiotics prescribed in the U.S. are unnecessary or inappropriate (CDC, 2024).
$20B
AMR infections add $20 billion annually to U.S. healthcare costs (CDC).
Partnership
Transforming Antimicrobial Stewardship Together
Our partnership with ARCHIMED enhances our capabilities in antimicrobial stewardship. Together, we are setting new standards in clinical decision support.
Science & Research Team
Meet the dedicated professionals driving our mission forward
Connect
Schedule Your Demo
Experience the future of antimicrobial stewardship with our interactive demo today.
News
Latest Insights and Updates
Stay informed with our featured press releases.
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients
The Arkstone platform has been used by doctors across the USA to diagnose and treat diseases in over 1 million patients, a major milestone reached in October 2025. The milestone underscores Arkstone’s leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding partnerships across the U.S. and around the world.
Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial Prescribing
This innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function
Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results
Leading Provider of Laboratory Infectious Disease Reporting Expands Precision-Guided Treatment Recommendations to Cultures and Stains
Take the Next Step, Try OneChoice®
No more guesswork. No more lookup tools. No more inaccuracies and inconsistencies. No more stopping to ask for directions.
